Sort
53,477 grants matching “addiction”
Endocannabinoid Targeting for Opioid Induced Respiratory Depression
$541,993Tally Marie Milnes · University Of Arizona · R01 · FY2025 · DA
Project 3: Perception of Tobacco Use in Vulnerable Populations
$541,948Herman Alfred Taylor · American Heart Association · P50 · FY2015 · HL
Project 3: Perception of Tobacco Use in Vulnerable Populations
$541,948Herman Alfred Taylor · American Heart Association · P50 · FY2014 · HL
Imaging Cortical Dopamine Transmission in Alcohol Dependence
$541,876Rajesh Narendran · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · AA
Translational Clinical Research Fellowship on Substance Use Disorders
$541,874Frances Rudnick Levin · Columbia University Health Sciences · T32 · FY2023 · DA
Project#1: Cognitive Control Training to Enhance CBT4CBT
$541,806Kathleen M Carroll · Yale University · P50 · FY2017 · DA
Genomic Predictors of Placebo response in Phase II AUD trials
$541,751Chamindi Seneviratne · University Of Maryland Baltimore · R01 · FY2021 · AA
Chemistry and Biology of 5-HT2C Receptor Ligands for Drug Abuse
$541,721Alan P. Kozikowski · University Of Illinois At Chicago · R01 · FY2009 · DA
DNA Methyltransferase Gene Expression in Colon Cancer
$541,697Stephen B Baylin · Johns Hopkins University · R01 · FY2023 · ES
DNA Methyltransferase Gene Expression in Colon Cancer
$541,697Stephen B Baylin · Johns Hopkins University · R01 · FY2021 · ES
DNA Methyltransferase Gene Expression in Colon Cancer
$541,697Stephen B Baylin · Johns Hopkins University · R01 · FY2022 · ES
DNA Methyltransferase Gene Expression in Colon Cancer
$541,697Stephen B Baylin · Johns Hopkins University · R01 · FY2020 · ES
Vagus nerve stimulation increases basal dopamine levels in the brain to decrease methamphetamine-mediated responses
$541,679Habibeh Khoshbouei · University Of Florida · R01 · FY2023 · DA
Molecular Dissection of Alcohol Use Disorder Through Targeted Brain Multi-omics
$541,594Matthew J Girgenti · Yale University · R01 · FY2025 · AA
Physiology and Genetics of GDNF Family of Ligands (GFLS)
$541,564Jeffrey D Milbrandt · Washington University · R01 · FY2007 · AG
Gene Delivery and Addiction
$541,554Brandon Harvey · National Institute On Drug Abuse · ZIA · FY2011 · DA
Instacortisol: A realtime and continuous assessment of cortisol in ISF
$541,544Manju Grover Venugopal · Guided Therapeutics · R44 · FY2012 · MH
Laboratory Resource
$541,529Neal L Benowitz · University Of California, San Francisco · P30 · FY2012 · DA
Evaluating the Geography of Medical Cannabis Facilities on Crime, Price and Use
$541,521Bridget Freisthler · University Of California Los Angeles · R01 · FY2012 · DA
Alcohol Problems &Service Dynamics after Welfare Reform
$541,518Public Health Institute · R01 · FY2004 · AA
Impact of Prescription Opioid Dose Changes on Cannabis Use and Clinical Outcomes
$541,509Benjamin J. Morasco · Oregon Health & Science University · R01 · FY2023 · DA
Gender Differences in a Follow-up of Opiate Users in Ca
$541,507Christine E Grella · University Of California Los Angeles · R01 · FY2006 · DA
The Role of Opioid Adherence Profiles in Cancer Pain Self-Management and Outcomes
$541,476Salimah H. Meghani · University Of Pennsylvania · R01 · FY2021 · NR
Interactive effects of Meth, HIV and cART on astrocyte/neuron function
$541,459Xiu-Ti Hu · Rush University Medical Center · R01 · FY2017 · DA
Accurate, low-cost, trackerless neuronavigation for transcranial magnetic stimulation
$541,418Angel V Peterchev · Duke University · R01 · FY2024 · MH